ubiome
Every record this desk has filed under ubiome, newest first, each with the number of sources it can still show you.
The SEC says uBiome's founders raised $60 million on a sham and sold $5 million of their own stock each. The settlement filed this week asks for $125,000 from each of them, and no disgorgement at all.
On September 14 the SEC filed consents and proposed final judgments against Jessica Richman and Zachary Apte, co-founders of the microbiome testing company uBiome, five and a half years after suing them for fraud. Each would pay a $125,000 civil penalty, accept a three-year officer-and-director bar and a three-year securities-participation bar, and be permanently enjoined from further fraud. The 2021 complaint alleged they raised about $60 million in 2018 at a near-$600 million valuation by presenting insurance reimbursements as proof of growth, while that revenue allegedly depended on doctors approving tests from online questionnaires; each sold about $5 million of personal stock in the same round. The complaint sought disgorgement and prejudgment interest. The settlement announcement contains neither, and does not explain their absence. A judge must still approve it.
Also filed undersecenforcementfraudstartupsinvestors
A record appears here because it carries ubiome in its own frontmatter. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.